Lipotype performed lipid analysis of bacteria for future antimicrobial strategies

Henri Deda April 16, 2018

What happened

Pseudomonas aeruginosa is a multi-drug resistant bacteria, and can cause serious illnesses such as pneumonia or sepsis syndromes. The publication from TU Braunschweig shows that, when grown under unaerobic biofilm conditions, the bacterium produces less of a protein, which binds specifically to the central hub of phospholipid metabolism.

With Lipotype shotgun lipidomics, a diverse response of Pseudomonas aeruginosa at the lipid head group and fatty acid level was demonstrated. This increased the susceptibility to a wide range of antibiotics which is important for the future development of new antimicrobial strategies.

Read the full publication

A phosphatidic acid-binding protein is important for lipid homeostasis and adaptation to anaerobic biofilm conditions in Pseudomonas aeruginosa – Biochemical Journal, 2018
Maike K Gronewald, Marco Massmig, Stefanie Hebecker, Linna Danne, Zofia Magnowska, Manfred Nimtz, Franz Narberhaus, Dieter Jahn, Dirk W Heinz, Lothar Jänsch, Jürgen Moser

Follow us on LinkedIn, Twitter, Instagram or Facebook, and subscribe to our newsletter to stay updated on lipids and lipidomics!

Publication, Academia

A new publication

Jeongeun Chae March 4, 2022

As a pioneer in the field of lipidomics, Lipotype not only provides lipidomic analysis services to customers but also contributes to science through carrying out its own research.

Lipidomics of Multiple Sclerosis

Henri Deda February 4, 2021

In multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the central nervous system, the body attacks the protective myelin sheath of neurons in the brain and the spinal cord. The damaged myelin causes communication problems between the central nervous system and the rest of the body. To this day, there is no cure for MS. Neurobiological researchers believe that MS does not only cause the clinical symptoms we look for as of today but also alters a patient’s lipid metabolism.

Multiomics analysis in CVD research

Henri Deda January 15, 2021

With an ever-increasing pool of accessible information and new tools to mine huge data sets, biology and medicine are moving from intervention to prevention. Omics sciences such as genomics and lipidomics are strong contributors to this paradigm shift. Being major players in cardiovascular disease research, genomics and lipidomics make a great multiomics pair. It matches the capacity to identify genetic predestinations with one or multiple snapshots of the lipid metabolic status to investigate cardiovascular diseases.